SYNAKIS
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous.
SYNAKIS
Social Links:
Industry:
Medical Medical Device
Founded:
2019-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.synakis.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Investors List
UTEST
UTEST investment in Pre Seed Round - Synakis
